PALVELLA THERAPEUTICS, INC. (PVLA)
Data as of , from SEC Form 4 filings.
See up to 3 months of PVLA. The 7-day demo opens the 1M and 3M ranges and puts PVLA on your watchlist.
Start 7-day demoLatest PVLA insider trades
About PALVELLA THERAPEUTICS, INC. (PVLA)
The SEC lists PALVELLA THERAPEUTICS, INC. under CIK 0001583648, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
PVLA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 22 | 40,719 | $6.17M |
| Option exercise | 14 | 26,438 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
PVLA insider transactions (Form 4)
2048 Form 4 filings on record, the earliest from Oct 28, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Christopher P. Kiritsy - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 12,350 | $0.00 | - | |
| Elaine J. Heron - Director | Grant or award | Non-Qualified Stock Option (right to buy) | 12,350 | $0.00 | - | |
| George M. Jenkins - Director | Open-market purchase | Common Stock | 2,500 | $20.13 | $50K | |
| George M. Jenkins - Director | Open-market purchase | Common Stock | 2,490 | $20.27 | $50K | |
| George M. Jenkins - Director | Open-market purchase | Common Stock | 4,000 | $12.93 | $52K | |
| Tadd S. Wessel - Director | Grant or award | Stock Option (right to buy) | 24,700 | $0.00 | - | |
| Jeffrey S. Martini - Officer | Grant or award | Stock Option (right to buy) | 126,416 | $0.00 | - | |
| Kathleen Goin - Officer | Grant or award | Stock Option (right to buy) | 27,843 | $0.00 | - | |
| Matthew E. Korenberg - Officer | Grant or award | Stock Option (right to buy) | 167,100 | $0.00 | - | |
| Wes Kaupinen - Officer | Grant or award | Stock Option (right to buy) | 417,806 | $0.00 | - | |
| Todd C. Davis - Director | Grant or award | Stock Option (right to buy) | 24,700 | $0.00 | - | |
| George M. Jenkins - Director | Grant or award | Stock Option (right to buy) | 24,700 | $0.00 | - | |
| Christopher P. Kiritsy - Director | Grant or award | Stock Option (right to buy) | 24,700 | $0.00 | - | |
| Elaine J. Heron - Director | Grant or award | Stock Option (right to buy) | 24,700 | $0.00 | - | |
| BVF PARTNERS L P | Other | Common Stock, $0.001 par value | 234,323 | - | - | |
| BVF PARTNERS L P | Other | Common Stock, $0.001 par value | 174,958 | - | - | |
| BVF PARTNERS L P | Other | Common Stock, $0.001 par value | 29,648 | - | - | |
| James A. Geraghty - Director | Derivative | Series F Preferred Stock, par value $0.001 per share | 1 | $0.01 | - | |
| Christopher P. Kiritsy - Director | Grant or award | Stock Option (right to buy) | 500 | $0.00 | - | |
| James A. Geraghty - Director | Open-market purchase | Series F Preferred Stock, par value $0.001 per share | 1 | $1.00 | $1 |
Recent PVLA Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JENKINS GEORGE M | Director | 27,500 | $3.70M | View on EDGAR | |
| Goin Kathleen | Officer | 4,302 |
PVLA insider trading FAQ
What is the latest insider trade for PVLA?
PALVELLA THERAPEUTICS, INC. (PVLA) had 5 insider filings in the last 90 days, with the most recent on 2026-09-18. The full record for PVLA runs to 48 Form 4 filings, the earliest from 2024-10-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PVLA stock?
No insider purchases of PVLA were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling PVLA stock?
22 insider sales of PVLA were filed in the last 90 days, totaling $6.17M.
Where can I see PVLA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PVLA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kathleen Goin view on EDGAR
- - George M. Jenkins view on EDGAR
- - Christopher P. Kiritsy view on EDGAR
- - Kathleen Goin view on EDGAR
- - Kathleen Goin view on EDGAR
- - Matthew Pauls view on EDGAR
- - Kathleen Goin view on EDGAR
- - Matthew E. Korenberg view on EDGAR
- - Christopher P. Kiritsy view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where PVLA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PVLA with a 7-day demo
- PVLA on your watchlist
- Every PVLA Form 4 filing on record
- Up to 3 months of PVLA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
